Shopping Cart
- Remove All
- Your shopping cart is currently empty
Raxibacumab (ABthrax), a human IgG1 monoclonal antibody, targets the protective antigen (PA) of Bacillus anthracis. It inhibits the toxic impact of anthrax by obstructing the PA's attachment to host cell receptors, preventing the subsequent harmful effects. This compound is utilized in anti-anthrax research [1] [2].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | Inquiry | Backorder | |
5 mg | Inquiry | Backorder |
Description | Raxibacumab (ABthrax), a human IgG1 monoclonal antibody, targets the protective antigen (PA) of Bacillus anthracis. It inhibits the toxic impact of anthrax by obstructing the PA's attachment to host cell receptors, preventing the subsequent harmful effects. This compound is utilized in anti-anthrax research [1] [2]. |
In vivo | Raxibacumab, administered intravenously at doses of 150 μg/kg or 300 μg/kg in a single dose, significantly improved the prognosis in rats when given within 6 hours after initial exposure to lethal anthrax toxin (LeTx) [3]. |
Alias | ABthrax |
Cas No. | 565451-13-0 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.